

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.76116713 |
| 2 | synaptic vesicle maturation (GO:0016188) | 4.76006600 |
| 3 | vocalization behavior (GO:0071625) | 4.49532354 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 4.45584677 |
| 5 | glutamate secretion (GO:0014047) | 4.35872720 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.22698695 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.11077300 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.10460973 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 4.08821930 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.08234131 |
| 11 | protein localization to synapse (GO:0035418) | 4.04117806 |
| 12 | gamma-aminobutyric acid transport (GO:0015812) | 3.92211503 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.85672046 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.74445407 |
| 15 | neuronal action potential propagation (GO:0019227) | 3.73103418 |
| 16 | locomotory exploration behavior (GO:0035641) | 3.71406390 |
| 17 | cell migration in hindbrain (GO:0021535) | 3.70697232 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.68247389 |
| 19 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.67955264 |
| 20 | proline transport (GO:0015824) | 3.66761644 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.63742751 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.62195920 |
| 23 | presynaptic membrane assembly (GO:0097105) | 3.60796320 |
| 24 | neuron recognition (GO:0008038) | 3.57535377 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 3.56733597 |
| 26 | presynaptic membrane organization (GO:0097090) | 3.51072543 |
| 27 | paraxial mesoderm development (GO:0048339) | 3.48959805 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 3.48496001 |
| 29 | axonal fasciculation (GO:0007413) | 3.41958911 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 3.39379928 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.36919880 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.35257965 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.31027265 |
| 34 | regulation of synaptic vesicle transport (GO:1902803) | 3.27867536 |
| 35 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17590334 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.14852835 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.14604058 |
| 38 | transmission of nerve impulse (GO:0019226) | 3.13831623 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 3.12668666 |
| 40 | dendrite morphogenesis (GO:0048813) | 3.12178308 |
| 41 | neurotransmitter transport (GO:0006836) | 3.11435249 |
| 42 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.08461200 |
| 43 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03328269 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00982271 |
| 45 | exploration behavior (GO:0035640) | 3.00277488 |
| 46 | nucleobase catabolic process (GO:0046113) | 2.99946358 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.98709273 |
| 48 | postsynaptic membrane organization (GO:0001941) | 2.98295831 |
| 49 | cerebellar granule cell differentiation (GO:0021707) | 2.94264074 |
| 50 | innervation (GO:0060384) | 2.94059772 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 2.93967650 |
| 52 | membrane hyperpolarization (GO:0060081) | 2.92309118 |
| 53 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.90569666 |
| 54 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.90256168 |
| 55 | limb bud formation (GO:0060174) | 2.86625791 |
| 56 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.85480778 |
| 57 | synapse assembly (GO:0007416) | 2.85315238 |
| 58 | auditory behavior (GO:0031223) | 2.84694032 |
| 59 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.83564711 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82232756 |
| 61 | membrane depolarization during action potential (GO:0086010) | 2.79490593 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 2.79203813 |
| 63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.78279337 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 2.77816323 |
| 65 | regulation of synapse structural plasticity (GO:0051823) | 2.77117673 |
| 66 | regulation of postsynaptic membrane potential (GO:0060078) | 2.76948363 |
| 67 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.76710608 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.76429775 |
| 69 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.76325086 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.73641067 |
| 71 | long-term memory (GO:0007616) | 2.72470065 |
| 72 | central nervous system myelination (GO:0022010) | 2.71228567 |
| 73 | axon ensheathment in central nervous system (GO:0032291) | 2.71228567 |
| 74 | apical protein localization (GO:0045176) | 2.71064342 |
| 75 | response to auditory stimulus (GO:0010996) | 2.70636922 |
| 76 | synapse organization (GO:0050808) | 2.68755208 |
| 77 | mating behavior (GO:0007617) | 2.68543781 |
| 78 | neuronal ion channel clustering (GO:0045161) | 2.68318341 |
| 79 | positive regulation of synapse assembly (GO:0051965) | 2.68062334 |
| 80 | adult walking behavior (GO:0007628) | 2.67901024 |
| 81 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.67279299 |
| 82 | regulation of gene silencing by miRNA (GO:0060964) | 2.67279299 |
| 83 | regulation of gene silencing by RNA (GO:0060966) | 2.67279299 |
| 84 | cell communication by electrical coupling (GO:0010644) | 2.66989347 |
| 85 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.65728187 |
| 86 | glycine transport (GO:0015816) | 2.65205494 |
| 87 | detection of temperature stimulus (GO:0016048) | 2.64203260 |
| 88 | regulation of neurotransmitter secretion (GO:0046928) | 2.63811965 |
| 89 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.63588268 |
| 90 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.60915445 |
| 91 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.60915445 |
| 92 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.60915445 |
| 93 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.60725291 |
| 94 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.60460149 |
| 95 | positive regulation of membrane potential (GO:0045838) | 2.59813182 |
| 96 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.59454833 |
| 97 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.57115274 |
| 98 | startle response (GO:0001964) | 2.55534907 |
| 99 | membrane depolarization (GO:0051899) | 2.55461523 |
| 100 | establishment of mitochondrion localization (GO:0051654) | 2.55411855 |
| 101 | establishment of nucleus localization (GO:0040023) | 2.54219949 |
| 102 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.53889955 |
| 103 | neuromuscular process controlling balance (GO:0050885) | 2.53147776 |
| 104 | regulation of synapse maturation (GO:0090128) | 2.52930751 |
| 105 | behavioral defense response (GO:0002209) | 2.51838488 |
| 106 | behavioral fear response (GO:0001662) | 2.51838488 |
| 107 | sodium ion export (GO:0071436) | 2.49810668 |
| 108 | regulation of synaptic plasticity (GO:0048167) | 2.48621931 |
| 109 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.48339467 |
| 110 | membrane repolarization (GO:0086009) | 2.48091138 |
| 111 | synaptic transmission (GO:0007268) | 2.47688853 |
| 112 | potassium ion homeostasis (GO:0055075) | 2.46151089 |
| 113 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.32515770 |
| 114 | notochord development (GO:0030903) | 2.30050105 |
| 115 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.29417260 |
| 116 | spinal cord development (GO:0021510) | 2.28466780 |
| 117 | neuronal stem cell maintenance (GO:0097150) | 2.27235485 |
| 118 | retinal ganglion cell axon guidance (GO:0031290) | 2.23747670 |
| 119 | lateral sprouting from an epithelium (GO:0060601) | 2.22771193 |
| 120 | ephrin receptor signaling pathway (GO:0048013) | 2.18217250 |
| 121 | limb development (GO:0060173) | 2.17813404 |
| 122 | appendage development (GO:0048736) | 2.17813404 |
| 123 | mechanosensory behavior (GO:0007638) | 2.17170277 |
| 124 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.17017405 |
| 125 | artery development (GO:0060840) | 2.15450597 |
| 126 | kidney morphogenesis (GO:0060993) | 2.14932766 |
| 127 | axon extension (GO:0048675) | 2.13908481 |
| 128 | axon extension involved in axon guidance (GO:0048846) | 2.13466002 |
| 129 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.13466002 |
| 130 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.12289980 |
| 131 | otic vesicle formation (GO:0030916) | 2.10961511 |
| 132 | inner ear receptor cell development (GO:0060119) | 2.10698102 |
| 133 | positive regulation of action potential (GO:0045760) | 2.09503770 |
| 134 | cochlea development (GO:0090102) | 2.08928614 |
| 135 | cerebral cortex cell migration (GO:0021795) | 2.04413566 |
| 136 | lung-associated mesenchyme development (GO:0060484) | 2.04128799 |
| 137 | convergent extension (GO:0060026) | 2.03679610 |
| 138 | pre-miRNA processing (GO:0031054) | 2.03440418 |
| 139 | dorsal/ventral axis specification (GO:0009950) | 2.03404641 |
| 140 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.03122063 |
| 141 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.02516488 |
| 142 | ganglion development (GO:0061548) | 2.02220743 |
| 143 | olfactory bulb development (GO:0021772) | 2.00369140 |
| 144 | negative regulation of astrocyte differentiation (GO:0048712) | 2.00167767 |
| 145 | forebrain neuron differentiation (GO:0021879) | 1.99815418 |
| 146 | gastrulation with mouth forming second (GO:0001702) | 1.99262536 |
| 147 | regulation of axon guidance (GO:1902667) | 1.99236384 |
| 148 | regulation of synapse assembly (GO:0051963) | 1.99149299 |
| 149 | C4-dicarboxylate transport (GO:0015740) | 1.99119337 |
| 150 | cranial nerve development (GO:0021545) | 1.96665522 |
| 151 | dendrite development (GO:0016358) | 1.96139404 |
| 152 | negative regulation of glial cell differentiation (GO:0045686) | 1.95930867 |
| 153 | camera-type eye morphogenesis (GO:0048593) | 1.94939395 |
| 154 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 1.94551977 |
| 155 | embryonic foregut morphogenesis (GO:0048617) | 1.94274860 |
| 156 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.94166434 |
| 157 | nonmotile primary cilium assembly (GO:0035058) | 1.93808754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.96240196 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38090726 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.84092546 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.81189167 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75928501 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73316756 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64219116 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64219116 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.52131532 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48821012 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45481708 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.45352319 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33386379 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31539707 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.29404831 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29338223 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.18261002 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17796784 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14961785 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.10731445 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10590778 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08002297 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07047006 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97951107 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.75494689 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75246214 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.75239361 |
| 28 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.70550700 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.65860638 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63436226 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.59807050 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59369080 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57714350 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56721962 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.55896706 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55675808 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55208468 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55072813 |
| 39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50207053 |
| 40 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49243612 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44289831 |
| 42 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43964831 |
| 43 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42378195 |
| 44 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40975901 |
| 45 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38346800 |
| 46 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37067536 |
| 47 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.34549440 |
| 48 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34266886 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33714313 |
| 50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.33526907 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31118651 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29487875 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28818223 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26713181 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.25706474 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25343225 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25293878 |
| 58 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.23401741 |
| 59 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22841847 |
| 60 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.22767153 |
| 61 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22714293 |
| 62 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22583097 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22115334 |
| 64 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.21911362 |
| 65 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.20777887 |
| 66 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.20486633 |
| 67 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19336693 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18759872 |
| 69 | * AR_19668381_ChIP-Seq_PC3_Human | 1.18208759 |
| 70 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15723635 |
| 71 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15275260 |
| 72 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.15029525 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13007503 |
| 74 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12350696 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10525473 |
| 76 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.10053122 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09331548 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09331548 |
| 79 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08404357 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07334893 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07144653 |
| 82 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06505350 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05711610 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05077082 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04792867 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04488087 |
| 87 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04261221 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03803241 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02997959 |
| 90 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02902972 |
| 91 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02713742 |
| 92 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.02657816 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02366257 |
| 94 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00911243 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00859916 |
| 96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00742352 |
| 97 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00350503 |
| 98 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.00072721 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99776324 |
| 100 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99746180 |
| 101 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.98499383 |
| 102 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98125332 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97739740 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96560200 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96410384 |
| 106 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94525640 |
| 107 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94397417 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94360776 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92957716 |
| 110 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92170860 |
| 111 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91284576 |
| 112 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91133085 |
| 113 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89994749 |
| 114 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89674277 |
| 115 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88490105 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88012404 |
| 117 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87904462 |
| 118 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87772387 |
| 119 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86058040 |
| 120 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84694362 |
| 121 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84514255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.34988118 |
| 2 | MP0003880_abnormal_central_pattern | 4.06181277 |
| 3 | MP0004270_analgesia | 3.27215998 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.10029680 |
| 5 | MP0001968_abnormal_touch/_nociception | 2.86418680 |
| 6 | MP0009046_muscle_twitch | 2.76552342 |
| 7 | MP0002734_abnormal_mechanical_nocicepti | 2.61666645 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.56616168 |
| 9 | MP0009745_abnormal_behavioral_response | 2.55622737 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.51664674 |
| 11 | MP0002064_seizures | 2.50929774 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.42543010 |
| 13 | MP0001486_abnormal_startle_reflex | 2.41942132 |
| 14 | MP0002272_abnormal_nervous_system | 2.27439386 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.26973802 |
| 16 | MP0004858_abnormal_nervous_system | 2.24505193 |
| 17 | MP0002736_abnormal_nociception_after | 2.24494452 |
| 18 | MP0000778_abnormal_nervous_system | 2.23279734 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.02233595 |
| 20 | MP0003122_maternal_imprinting | 1.95171064 |
| 21 | MP0002184_abnormal_innervation | 1.94935958 |
| 22 | MP0001984_abnormal_olfaction | 1.87864484 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.86224733 |
| 24 | MP0001970_abnormal_pain_threshold | 1.79318332 |
| 25 | MP0006276_abnormal_autonomic_nervous | 1.78004918 |
| 26 | MP0005394_taste/olfaction_phenotype | 1.76236970 |
| 27 | MP0005499_abnormal_olfactory_system | 1.76236970 |
| 28 | MP0003787_abnormal_imprinting | 1.74177600 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.68729325 |
| 30 | MP0000955_abnormal_spinal_cord | 1.65807365 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.65716395 |
| 32 | MP0003937_abnormal_limbs/digits/tail_de | 1.63960478 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.61899005 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.61425609 |
| 35 | MP0002822_catalepsy | 1.59017974 |
| 36 | MP0003941_abnormal_skin_development | 1.56004013 |
| 37 | MP0004885_abnormal_endolymph | 1.54536548 |
| 38 | MP0000049_abnormal_middle_ear | 1.51884338 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.48115251 |
| 40 | MP0004142_abnormal_muscle_tone | 1.43412386 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.42338232 |
| 42 | MP0002697_abnormal_eye_size | 1.41448985 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.39200572 |
| 44 | MP0004811_abnormal_neuron_physiology | 1.37673529 |
| 45 | MP0003329_amyloid_beta_deposits | 1.37264675 |
| 46 | MP0008569_lethality_at_weaning | 1.33279974 |
| 47 | MP0005187_abnormal_penis_morphology | 1.31544613 |
| 48 | MP0000566_synostosis | 1.30830056 |
| 49 | MP0004924_abnormal_behavior | 1.30736978 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.30736978 |
| 51 | MP0001293_anophthalmia | 1.28484192 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.25027740 |
| 53 | MP0003942_abnormal_urinary_system | 1.23477890 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.22717519 |
| 55 | MP0002938_white_spotting | 1.22163604 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 1.21530558 |
| 57 | MP0006292_abnormal_olfactory_placode | 1.21431955 |
| 58 | MP0002752_abnormal_somatic_nervous | 1.19350450 |
| 59 | MP0003385_abnormal_body_wall | 1.17392245 |
| 60 | MP0003755_abnormal_palate_morphology | 1.16880542 |
| 61 | MP0002152_abnormal_brain_morphology | 1.14395000 |
| 62 | MP0003123_paternal_imprinting | 1.13336378 |
| 63 | MP0003137_abnormal_impulse_conducting | 1.12171988 |
| 64 | MP0003121_genomic_imprinting | 1.08590411 |
| 65 | MP0001286_abnormal_eye_development | 1.08075156 |
| 66 | MP0002229_neurodegeneration | 1.06640555 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.03743556 |
| 68 | MP0003935_abnormal_craniofacial_develop | 1.03351768 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 1.02520633 |
| 70 | MP0003567_abnormal_fetal_cardiomyocyte | 1.01906082 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.01007875 |
| 72 | MP0004272_abnormal_basement_membrane | 1.00456158 |
| 73 | MP0004085_abnormal_heartbeat | 0.99978572 |
| 74 | MP0003136_yellow_coat_color | 0.98985015 |
| 75 | MP0001177_atelectasis | 0.98563081 |
| 76 | MP0003634_abnormal_glial_cell | 0.96385363 |
| 77 | MP0001188_hyperpigmentation | 0.95876870 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.94812151 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 0.94738760 |
| 80 | MP0001502_abnormal_circadian_rhythm | 0.93642979 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.93391677 |
| 82 | MP0003632_abnormal_nervous_system | 0.92983709 |
| 83 | MP0003890_abnormal_embryonic-extraembry | 0.92812882 |
| 84 | MP0003861_abnormal_nervous_system | 0.92364125 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.92079073 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.92037411 |
| 87 | MP0004742_abnormal_vestibular_system | 0.90239795 |
| 88 | MP0000428_abnormal_craniofacial_morphol | 0.90160570 |
| 89 | MP0001905_abnormal_dopamine_level | 0.89169336 |
| 90 | MP0003633_abnormal_nervous_system | 0.89052682 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 0.88096035 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.87141659 |
| 93 | MP0002084_abnormal_developmental_patter | 0.86578066 |
| 94 | MP0003631_nervous_system_phenotype | 0.86107447 |
| 95 | MP0002751_abnormal_autonomic_nervous | 0.85987177 |
| 96 | MP0000920_abnormal_myelination | 0.85690501 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.84989055 |
| 98 | MP0001529_abnormal_vocalization | 0.84624992 |
| 99 | MP0003938_abnormal_ear_development | 0.84212678 |
| 100 | MP0000579_abnormal_nail_morphology | 0.83713933 |
| 101 | MP0002116_abnormal_craniofacial_bone | 0.83163349 |
| 102 | MP0000462_abnormal_digestive_system | 0.82034290 |
| 103 | MP0002081_perinatal_lethality | 0.81775424 |
| 104 | MP0005253_abnormal_eye_physiology | 0.81693717 |
| 105 | MP0003879_abnormal_hair_cell | 0.81573827 |
| 106 | MP0003283_abnormal_digestive_organ | 0.81515306 |
| 107 | MP0003011_delayed_dark_adaptation | 0.81308315 |
| 108 | MP0002254_reproductive_system_inflammat | 0.80459843 |
| 109 | MP0002069_abnormal_eating/drinking_beha | 0.80002218 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.79838713 |
| 111 | MP0004145_abnormal_muscle_electrophysio | 0.79143695 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.79135784 |
| 113 | MP0009703_decreased_birth_body | 0.79002629 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.78958346 |
| 115 | MP0000026_abnormal_inner_ear | 0.78869071 |
| 116 | MP0009672_abnormal_birth_weight | 0.76997647 |
| 117 | MP0000751_myopathy | 0.76833879 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.76734634 |
| 119 | MP0000432_abnormal_head_morphology | 0.76513251 |
| 120 | MP0005257_abnormal_intraocular_pressure | 0.75913657 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.75863064 |
| 122 | MP0003315_abnormal_perineum_morphology | 0.74971908 |
| 123 | MP0003690_abnormal_glial_cell | 0.74769835 |
| 124 | MP0005195_abnormal_posterior_eye | 0.73358323 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.72204760 |
| 126 | MP0008872_abnormal_physiological_respon | 0.71130044 |
| 127 | MP0004133_heterotaxia | 0.70356911 |
| 128 | MP0002090_abnormal_vision | 0.70053545 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.68456660 |
| 130 | MP0002233_abnormal_nose_morphology | 0.67619324 |
| 131 | MP0001943_abnormal_respiration | 0.67009492 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.66861353 |
| 133 | MP0000534_abnormal_ureter_morphology | 0.64769838 |
| 134 | MP0003119_abnormal_digestive_system | 0.63288194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.26190117 |
| 2 | Myokymia (HP:0002411) | 4.46734191 |
| 3 | Febrile seizures (HP:0002373) | 4.37956455 |
| 4 | Focal seizures (HP:0007359) | 4.32631175 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.19234425 |
| 6 | Atonic seizures (HP:0010819) | 3.82233410 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.64467805 |
| 8 | Hyperventilation (HP:0002883) | 3.53525027 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 3.41507021 |
| 10 | Action tremor (HP:0002345) | 3.22322465 |
| 11 | Termporal pattern (HP:0011008) | 3.18039178 |
| 12 | Insidious onset (HP:0003587) | 3.18039178 |
| 13 | Abnormality of the corticospinal tract (HP:0002492) | 3.16672985 |
| 14 | Dialeptic seizures (HP:0011146) | 3.10082776 |
| 15 | Absence seizures (HP:0002121) | 3.07137550 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 2.92299462 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 2.73352907 |
| 18 | Hepatoblastoma (HP:0002884) | 2.65914141 |
| 19 | Amblyopia (HP:0000646) | 2.64164573 |
| 20 | Bilateral microphthalmos (HP:0007633) | 2.63633563 |
| 21 | Visual hallucinations (HP:0002367) | 2.62001222 |
| 22 | Ankle clonus (HP:0011448) | 2.61266165 |
| 23 | Hemiparesis (HP:0001269) | 2.57369587 |
| 24 | Dysdiadochokinesis (HP:0002075) | 2.54999676 |
| 25 | Excessive salivation (HP:0003781) | 2.50899987 |
| 26 | Drooling (HP:0002307) | 2.50899987 |
| 27 | Neurofibrillary tangles (HP:0002185) | 2.50069248 |
| 28 | Spastic gait (HP:0002064) | 2.47890712 |
| 29 | Septo-optic dysplasia (HP:0100842) | 2.42664186 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.32583773 |
| 31 | Broad-based gait (HP:0002136) | 2.26860205 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.22535536 |
| 33 | Dysmetria (HP:0001310) | 2.21774324 |
| 34 | Megalencephaly (HP:0001355) | 2.20271458 |
| 35 | Failure to thrive in infancy (HP:0001531) | 2.18180592 |
| 36 | Cortical dysplasia (HP:0002539) | 2.16661917 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.16389133 |
| 38 | Lower limb muscle weakness (HP:0007340) | 2.16310891 |
| 39 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15449085 |
| 40 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15449085 |
| 41 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.12059010 |
| 42 | Bronchomalacia (HP:0002780) | 2.11746317 |
| 43 | Intestinal atresia (HP:0011100) | 2.11453516 |
| 44 | Cutaneous syndactyly (HP:0012725) | 2.10901362 |
| 45 | Pheochromocytoma (HP:0002666) | 2.10031885 |
| 46 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08703622 |
| 47 | Status epilepticus (HP:0002133) | 2.08582556 |
| 48 | Scanning speech (HP:0002168) | 2.07571670 |
| 49 | Absent speech (HP:0001344) | 2.06890523 |
| 50 | Sensory axonal neuropathy (HP:0003390) | 2.06702130 |
| 51 | Genetic anticipation (HP:0003743) | 2.04141650 |
| 52 | Renal hypoplasia (HP:0000089) | 2.03807785 |
| 53 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.03612378 |
| 54 | Limb dystonia (HP:0002451) | 2.03310742 |
| 55 | Aplasia involving bones of the extremities (HP:0009825) | 2.02642714 |
| 56 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.02642714 |
| 57 | Aplasia of the phalanges of the hand (HP:0009802) | 2.02642714 |
| 58 | Abnormal eating behavior (HP:0100738) | 2.02140920 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.01382390 |
| 60 | Optic nerve hypoplasia (HP:0000609) | 2.00112407 |
| 61 | Choanal stenosis (HP:0000452) | 1.98565726 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 1.98371153 |
| 63 | Ulnar claw (HP:0001178) | 1.95119348 |
| 64 | Specific learning disability (HP:0001328) | 1.94721160 |
| 65 | Alacrima (HP:0000522) | 1.94631806 |
| 66 | Thyroid-stimulating hormone excess (HP:0002925) | 1.91651059 |
| 67 | Depression (HP:0000716) | 1.90950488 |
| 68 | Intention tremor (HP:0002080) | 1.90429607 |
| 69 | Coronal craniosynostosis (HP:0004440) | 1.89676014 |
| 70 | Generalized hypotonia (HP:0001290) | 1.89365886 |
| 71 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88893682 |
| 72 | Preaxial foot polydactyly (HP:0001841) | 1.88548515 |
| 73 | Truncal ataxia (HP:0002078) | 1.88281782 |
| 74 | Turricephaly (HP:0000262) | 1.88169146 |
| 75 | Vitreoretinal degeneration (HP:0000655) | 1.87909272 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 1.87449783 |
| 77 | Papillary thyroid carcinoma (HP:0002895) | 1.86165768 |
| 78 | Steppage gait (HP:0003376) | 1.86054847 |
| 79 | Hypsarrhythmia (HP:0002521) | 1.85316757 |
| 80 | Ventricular fibrillation (HP:0001663) | 1.84802717 |
| 81 | Labial hypoplasia (HP:0000066) | 1.84740054 |
| 82 | Thickened helices (HP:0000391) | 1.84504454 |
| 83 | Gait imbalance (HP:0002141) | 1.83162800 |
| 84 | Postural instability (HP:0002172) | 1.81862879 |
| 85 | Abnormality of the astrocytes (HP:0100707) | 1.80982815 |
| 86 | Astrocytoma (HP:0009592) | 1.80982815 |
| 87 | Generalized myoclonic seizures (HP:0002123) | 1.78910371 |
| 88 | Impaired social interactions (HP:0000735) | 1.78901271 |
| 89 | Abnormal social behavior (HP:0012433) | 1.78901271 |
| 90 | Anophthalmia (HP:0000528) | 1.78307127 |
| 91 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77661804 |
| 92 | Bifid tongue (HP:0010297) | 1.75786081 |
| 93 | Poor eye contact (HP:0000817) | 1.74776025 |
| 94 | Midline defect of the nose (HP:0004122) | 1.74374206 |
| 95 | Shallow orbits (HP:0000586) | 1.72820979 |
| 96 | Cutaneous finger syndactyly (HP:0010554) | 1.72207870 |
| 97 | Abnormality of the diencephalon (HP:0010662) | 1.71527780 |
| 98 | Urinary urgency (HP:0000012) | 1.70732444 |
| 99 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.70059464 |
| 100 | Gastrointestinal atresia (HP:0002589) | 1.69125056 |
| 101 | Genital tract atresia (HP:0001827) | 1.68347266 |
| 102 | Hypoplastic female external genitalia (HP:0012815) | 1.67081295 |
| 103 | Agitation (HP:0000713) | 1.67037695 |
| 104 | Colon cancer (HP:0003003) | 1.66420707 |
| 105 | Cupped ear (HP:0000378) | 1.66142774 |
| 106 | Split foot (HP:0001839) | 1.65928831 |
| 107 | Torticollis (HP:0000473) | 1.64823683 |
| 108 | Abnormality of salivation (HP:0100755) | 1.64350567 |
| 109 | Onion bulb formation (HP:0003383) | 1.64095135 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 1.63977312 |
| 111 | Vaginal atresia (HP:0000148) | 1.63557137 |
| 112 | Neoplasm of the heart (HP:0100544) | 1.63550557 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.63532189 |
| 114 | Anomalous pulmonary venous return (HP:0010772) | 1.63529007 |
| 115 | Anxiety (HP:0000739) | 1.63337751 |
| 116 | Abnormality of the antihelix (HP:0009738) | 1.63313287 |
| 117 | Abnormality of the aortic arch (HP:0012303) | 1.61875298 |
| 118 | Broad metatarsal (HP:0001783) | 1.61689006 |
| 119 | Abnormality of pain sensation (HP:0010832) | 1.61184860 |
| 120 | Impaired pain sensation (HP:0007328) | 1.61184860 |
| 121 | Exotropia (HP:0000577) | 1.61183564 |
| 122 | Hemiplegia (HP:0002301) | 1.61062339 |
| 123 | Decreased lacrimation (HP:0000633) | 1.60463374 |
| 124 | Abnormality of the labia minora (HP:0012880) | 1.60410550 |
| 125 | Ependymoma (HP:0002888) | 1.58992009 |
| 126 | Hammertoe (HP:0001765) | 1.58069785 |
| 127 | Polyphagia (HP:0002591) | 1.57464218 |
| 128 | Micropenis (HP:0000054) | 1.57320036 |
| 129 | Neonatal short-limb short stature (HP:0008921) | 1.56786988 |
| 130 | Spastic paraplegia (HP:0001258) | 1.56618109 |
| 131 | Central scotoma (HP:0000603) | 1.56458258 |
| 132 | Protruding tongue (HP:0010808) | 1.55858523 |
| 133 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.55795472 |
| 134 | Short 4th metacarpal (HP:0010044) | 1.55795472 |
| 135 | Glioma (HP:0009733) | 1.55564957 |
| 136 | Bradycardia (HP:0001662) | 1.54378399 |
| 137 | Vertebral arch anomaly (HP:0008438) | 1.54346741 |
| 138 | Paraplegia (HP:0010550) | 1.54243125 |
| 139 | Horizontal nystagmus (HP:0000666) | 1.53957792 |
| 140 | Morphological abnormality of the middle ear (HP:0008609) | 1.53906848 |
| 141 | Lissencephaly (HP:0001339) | 1.53495280 |
| 142 | Partial duplication of thumb phalanx (HP:0009944) | 1.52806500 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.52691301 |
| 144 | Inability to walk (HP:0002540) | 1.52463087 |
| 145 | Volvulus (HP:0002580) | 1.52250983 |
| 146 | Absent eyebrow (HP:0002223) | 1.51024149 |
| 147 | Absent septum pellucidum (HP:0001331) | 1.50866444 |
| 148 | Scrotal hypoplasia (HP:0000046) | 1.50546780 |
| 149 | Hypoplastic labia majora (HP:0000059) | 1.50023435 |
| 150 | Esophageal atresia (HP:0002032) | 1.49820937 |
| 151 | Nephronophthisis (HP:0000090) | 1.49141624 |
| 152 | Abnormality of the ischium (HP:0003174) | 1.49044070 |
| 153 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.45922147 |
| 154 | Supernumerary spleens (HP:0009799) | 1.44628539 |
| 155 | Pancreatic fibrosis (HP:0100732) | 1.43262983 |
| 156 | Abnormality of the pubic bones (HP:0003172) | 1.42998953 |
| 157 | Omphalocele (HP:0001539) | 1.42443828 |
| 158 | Pachygyria (HP:0001302) | 1.42020551 |
| 159 | Myelomeningocele (HP:0002475) | 1.41715236 |
| 160 | Shawl scrotum (HP:0000049) | 1.41705448 |
| 161 | Retinal dysplasia (HP:0007973) | 1.41457473 |
| 162 | Bifid scrotum (HP:0000048) | 1.41238390 |
| 163 | Chorioretinal atrophy (HP:0000533) | 1.41138022 |
| 164 | Neoplasm of the oral cavity (HP:0100649) | 1.40787926 |
| 165 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.40704047 |
| 166 | Sleep apnea (HP:0010535) | 1.40342220 |
| 167 | True hermaphroditism (HP:0010459) | 1.40205450 |
| 168 | Abnormality of the labia (HP:0000058) | 1.39243711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.50824375 |
| 2 | MARK1 | 3.15316298 |
| 3 | EPHA4 | 2.96221266 |
| 4 | MAP3K9 | 2.68111586 |
| 5 | MAP3K4 | 2.63242686 |
| 6 | CASK | 2.59644715 |
| 7 | GRK5 | 2.48804931 |
| 8 | NTRK2 | 2.31718048 |
| 9 | PAK6 | 2.17458602 |
| 10 | WNK3 | 2.11671997 |
| 11 | NTRK1 | 2.07744998 |
| 12 | MAP2K7 | 2.04850257 |
| 13 | MINK1 | 2.00441384 |
| 14 | MAP2K4 | 1.97950867 |
| 15 | DAPK2 | 1.89297449 |
| 16 | STK38L | 1.67955652 |
| 17 | AKT3 | 1.61584212 |
| 18 | TYRO3 | 1.59027801 |
| 19 | LATS1 | 1.58742965 |
| 20 | MKNK2 | 1.58284415 |
| 21 | PNCK | 1.49229652 |
| 22 | TNIK | 1.48851114 |
| 23 | STK39 | 1.48781344 |
| 24 | LATS2 | 1.46103085 |
| 25 | WNK1 | 1.41747487 |
| 26 | MAPK13 | 1.41521553 |
| 27 | OXSR1 | 1.41126906 |
| 28 | LMTK2 | 1.40876484 |
| 29 | SGK494 | 1.35325594 |
| 30 | SGK223 | 1.35325594 |
| 31 | PHKG1 | 1.33789026 |
| 32 | PHKG2 | 1.33789026 |
| 33 | PRPF4B | 1.31786145 |
| 34 | BCR | 1.31734614 |
| 35 | CDK5 | 1.30228108 |
| 36 | STK38 | 1.28844189 |
| 37 | UHMK1 | 1.23972357 |
| 38 | TSSK6 | 1.16341611 |
| 39 | PLK2 | 1.15722043 |
| 40 | PAK3 | 1.15117564 |
| 41 | FGFR2 | 1.14424994 |
| 42 | CAMK1D | 1.12383274 |
| 43 | MKNK1 | 1.09934942 |
| 44 | TRIM28 | 1.07305490 |
| 45 | CDK12 | 1.05384263 |
| 46 | FGFR1 | 1.05279404 |
| 47 | KSR2 | 1.04957319 |
| 48 | SGK2 | 1.02367237 |
| 49 | FRK | 1.02216572 |
| 50 | CDC7 | 1.01527410 |
| 51 | PRKCG | 1.01504696 |
| 52 | KSR1 | 1.01076253 |
| 53 | TTK | 0.99351643 |
| 54 | PRKD3 | 0.99212464 |
| 55 | DMPK | 0.96061394 |
| 56 | CAMK2A | 0.94795774 |
| 57 | MARK2 | 0.93837645 |
| 58 | ADRBK2 | 0.91533644 |
| 59 | FER | 0.91371711 |
| 60 | PDGFRA | 0.90493927 |
| 61 | ERBB4 | 0.90314082 |
| 62 | ICK | 0.90214090 |
| 63 | SRPK1 | 0.88226439 |
| 64 | DYRK1A | 0.87805914 |
| 65 | CDK18 | 0.85381821 |
| 66 | CDK15 | 0.85178530 |
| 67 | CSNK1G1 | 0.84816147 |
| 68 | EPHB2 | 0.84565532 |
| 69 | PKN1 | 0.83069853 |
| 70 | CDK14 | 0.82995605 |
| 71 | GRK1 | 0.82908122 |
| 72 | CDC42BPA | 0.79611647 |
| 73 | CAMK4 | 0.79546193 |
| 74 | MAPK15 | 0.79295120 |
| 75 | SIK2 | 0.78902217 |
| 76 | CSNK1G2 | 0.77701590 |
| 77 | CDK19 | 0.77059413 |
| 78 | CAMK1G | 0.75792071 |
| 79 | BMPR1B | 0.74481919 |
| 80 | CAMK2B | 0.74336767 |
| 81 | SGK3 | 0.73153298 |
| 82 | PLK3 | 0.72781138 |
| 83 | STK11 | 0.72364632 |
| 84 | CAMKK1 | 0.71736042 |
| 85 | CDK11A | 0.71136568 |
| 86 | WEE1 | 0.71122618 |
| 87 | RET | 0.69417649 |
| 88 | TIE1 | 0.68961000 |
| 89 | LIMK1 | 0.68840132 |
| 90 | GRK7 | 0.67878891 |
| 91 | ADRBK1 | 0.67597765 |
| 92 | CAMK2D | 0.66420828 |
| 93 | EPHA3 | 0.64940194 |
| 94 | PRKCE | 0.62597513 |
| 95 | PIK3CA | 0.61140444 |
| 96 | CAMK1 | 0.59808744 |
| 97 | DYRK3 | 0.59768224 |
| 98 | TAF1 | 0.59618927 |
| 99 | BRD4 | 0.59520098 |
| 100 | ROCK2 | 0.58912042 |
| 101 | STK3 | 0.58785384 |
| 102 | MET | 0.57958346 |
| 103 | DYRK2 | 0.57390396 |
| 104 | CAMK2G | 0.56673749 |
| 105 | PRKCZ | 0.55411450 |
| 106 | NEK2 | 0.53817372 |
| 107 | SGK1 | 0.53281312 |
| 108 | ERBB2 | 0.52988803 |
| 109 | MAPK7 | 0.52792817 |
| 110 | NEK6 | 0.52351412 |
| 111 | ERBB3 | 0.52091345 |
| 112 | PRKAA1 | 0.51344134 |
| 113 | PRKDC | 0.51207897 |
| 114 | PINK1 | 0.50909624 |
| 115 | DDR2 | 0.50324100 |
| 116 | PRKCH | 0.50230601 |
| 117 | CSNK1A1L | 0.49394406 |
| 118 | CSNK1G3 | 0.49309408 |
| 119 | ROCK1 | 0.48831935 |
| 120 | ZAK | 0.48012307 |
| 121 | PAK2 | 0.47932437 |
| 122 | CDK3 | 0.47898843 |
| 123 | RPS6KA3 | 0.47126785 |
| 124 | MAP3K7 | 0.46784655 |
| 125 | PLK1 | 0.46723275 |
| 126 | MAPK10 | 0.45509322 |
| 127 | CSNK1E | 0.44807375 |
| 128 | DAPK1 | 0.44219987 |
| 129 | CSNK1D | 0.43494025 |
| 130 | FGR | 0.42577889 |
| 131 | PTK2 | 0.42343596 |
| 132 | MAP3K2 | 0.40383906 |
| 133 | PRKACA | 0.39503874 |
| 134 | MAP2K6 | 0.39186625 |
| 135 | PRKACB | 0.38589365 |
| 136 | WNK4 | 0.38313873 |
| 137 | PRKG1 | 0.37680124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.48572477 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.84526562 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.74890787 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.37066301 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36394895 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.20656883 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.12884314 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.08430391 |
| 9 | Taste transduction_Homo sapiens_hsa04742 | 1.94760442 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88021701 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.81654394 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.77422661 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72970300 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.70324220 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.67511026 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.64690149 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58320003 |
| 18 | Axon guidance_Homo sapiens_hsa04360 | 1.53078344 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52752008 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50412510 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.49607932 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47517218 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41423934 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.40916350 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40596708 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.36871720 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33438625 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32628936 |
| 29 | Adherens junction_Homo sapiens_hsa04520 | 1.31120922 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28132154 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24158654 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24146626 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24107939 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19099829 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17868277 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16796501 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16224738 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15993015 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15957863 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15952658 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15208613 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.13230061 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11963459 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11791818 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10393849 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09059183 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08948063 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 1.08490253 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08053470 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01049667 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.99924684 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.97972619 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97822014 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97261562 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.96404653 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96147801 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95313680 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91257543 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89295203 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87834711 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.85067731 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83349006 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83344897 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83128419 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82895918 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82180155 |
| 67 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81483900 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81005775 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80275148 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79954021 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79077652 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78532367 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76931683 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76568722 |
| 75 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76159002 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75199005 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75198690 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74690167 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.74380108 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73111062 |
| 81 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71760772 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70486105 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70235037 |
| 84 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.69562415 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69126626 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68434938 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67277239 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66744911 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66165719 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64606641 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64366499 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63346994 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62856357 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61213523 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61139350 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59997917 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59081679 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58847062 |
| 99 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58076973 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57967157 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57760486 |
| 102 | * Tight junction_Homo sapiens_hsa04530 | 0.57535738 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57333550 |
| 104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57046971 |
| 105 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56950758 |
| 106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56013583 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55334829 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55198243 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54176723 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53890824 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53704187 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53564772 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53464734 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53191610 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.52454778 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51989711 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51462485 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49455247 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49285734 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47281318 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46669736 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44697424 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44102345 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42573683 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42127810 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39740695 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39483016 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39330668 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38964814 |
| 130 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38580000 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.37220831 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34492125 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34224675 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | 0.34078743 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.33212807 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32304440 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30455778 |

